$5.70
arrow_drop_up8.98%Key Stats | |
---|---|
Open | $5.37 |
Prev. Close | $5.23 |
EPS | -3.99 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $28.83M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 5.26 | 5.70 |
52 Week Range | 3.44 | 8.48 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -3.99 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Pluri Inc. faces potential Nasdaq delisting over equity shortfall - Investing.com
Pluri Subsidiary Ever After Foods Secured $10 Million Strategic Investment to Solve Cultivated Food Scalability Challenges
U.S. National Institutes of Health Exercises Option to Fund $1.4 Million 2nd Year Budget for Pluri’s PLX-R18 Acute Radiation Syndrome Contract
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
Unleashing the Power of MAIT Cells: Pluri Launches Novel Immunotherapy Platform for Solid Tumor Cancer Treatment
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences